SNT1/FRS2 Mediates Germinal Vesicle Breakdown Induced by an Activated FGF Receptor1 in Xenopus Oocytes

• Published in: The Journal of biological chemistry 2002-09, Vol.277 (36), p.33196-33204
• Main Authors: Mood, Kathleen, Friesel, Robert, Daar, Ira O.
• Format: Article
• Language: English
• Subjects: Adaptor Proteins, Signal Transducing; Animals; Binding Sites; Blotting, Western; Cell Cycle; Enzyme Inhibitors - pharmacology; Germ Cells - metabolism; Histones - metabolism; Intracellular Signaling Peptides and Proteins; Ligands; MAP Kinase Signaling System; Membrane Proteins - metabolism; Mutation; Oocytes - metabolism; Phosphoproteins - metabolism; Phosphorylation; Plasmids - metabolism; Precipitin Tests; Progesterone - metabolism; Protein Binding; Protein Kinases - metabolism; Proteins - metabolism; Receptor Protein-Tyrosine Kinases - metabolism; Receptor, Fibroblast Growth Factor, Type 1; Receptors, Fibroblast Growth Factor - metabolism; RNA - metabolism; Xenopus
• ISSN: 0021-9258; 1083-351X
• DOI: 10.1074/jbc.M203894200

The docking protein SNT1/FRS2 (fibroblast growth factor receptor substrate 2) is implicated in the transmission of extracellular signals from the fibroblast growth factor receptor (FGFR), which plays vital roles during embryogenesis. Activating FGFR mutations cause several craniosynostoses and dwarfism syndromes in humans. Here we show that the Xenopus homolog of mammalian FRS-2 (XFRS2) is essential for the induction of oocyte maturation by an XFGFR1 harboring an activating mutation (XFGFR1act). Using a dominant-negative form of kinase suppressor of Ras, we show the Mek activity is required for germinal vesicle breakdown (GVBD) induced by co-expression of XFGFR1act and XFRS2, but this activity is not required for progesterone-induced GVBD. Furthermore, Mek/MAPK activity is critical for the induction and/or maintenance of H1 kinase activity at metaphase of meiosis II in progesterone-treated oocytes. An activated XFGFR1 containing a mutation in the phospholipase Cγ binding site (XFGFR1actY672F) displayed a reduced ability to induce cell-cycle progression in oocytes, suggesting phospholipase Cγ may not be necessary but that it augments XFGFR signaling in this system. Oocytes co-expressing XFGFR1act and XFRS2 showed substantial H1 kinase activity, but this activity was blocked when the oocytes were treated with the phosphatidylinositol 3-kinase inhibitor LY294002. Although phosphatidylinositol 3-kinase activity is essential for XFGFR1act/XFRS2-induced oocyte maturation, this activity is not required for maturation induced by progesterone. Finally, ectopic expression of Xspry2, a negative regulator of XFGFR signaling, greatly reduced MAPK activation and GVBD induced by the expression of either XFGFR1act plus XFRS2 or activated Ras (H-RasV12). In contrast, Xspry2 did not prevent GVBD induced by an activated form of Raf1, suggesting that Xspry2 exerts its inhibitory function upstream or parallel to Raf and downstream of Ras.